Risk factor
Resilient to price shocks
Profitability factor
Greatly undervalued vs peers
About
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was founded in 1996 and is headquartered in Seoul, South Korea.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITDA, reasonably
Target Price
The average target price of 041830.KQ is 37000 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to
Buy
Sell